Vacuolated PAS-Positive Lymphocytes on Blood Smear: An Easy Screening Tool and a Possible Biomarker for Monitoring Therapeutic Responses in Late Onset Pompe Disease (LOPD)-Reference-Cited by-同舟云学术

Vacuolated PAS-Positive Lymphocytes on Blood Smear: An Easy Screening Tool and a Possible Biomarker for Monitoring Therapeutic Responses in Late Onset Pompe Disease (LOPD)

Published:2018-10-22 Issue: Volume:9 Page:
ISSN:1664-2295
Container-title:Frontiers in Neurology
language:
Short-container-title:Front. Neurol.

Author:

Parisi Daniela,Musumeci Olimpia,Mondello Stefania,Brizzi Teresa,Oteri Rosaria,Migliorato Alba,Ciranni Annamaria,Mongini Tiziana E.,Rodolico Carmelo,Vita Giuseppe,Toscano Antonio

Publisher

Frontiers Media SA

Subject

Neurology (clinical),Neurology

Reference28 articles.

1. Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency;Hirschhorn,2001

2. Pompe's disease;van;Lancet,2008

3. Pathophysiological mechanisms in Glycogenosis type II;Toscano,2012

4. Italian GSDII Group Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years;Angelini;J Neurol.,2012

5. Childhood Pompe disease: clinical spectrum and genotype in 31 patients;van Capelle;Orphanet J Rare Dis.,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Late-Onset Pompe Disease with Normal Creatine Kinase Levels: The Importance of Rheumatological Suspicion;International Journal of Molecular Sciences;2023-11-03

2. A Comprehensive Update on Late-Onset Pompe Disease;Biomolecules;2023-08-22

3. Recommendations for Infantile-Onset and Late-Onset Pompe Disease: An Iranian Consensus;Frontiers in Neurology;2021-09-21

4. Novel autophagic vacuolar myopathies: Phenotype and genotype features;Neuropathology and Applied Neurobiology;2021-02

5. Quantifying lymphocyte vacuolization serves as a measure of CLN3 disease severity;JIMD Reports;2020-06-02